<DOC>
	<DOCNO>NCT00061321</DOCNO>
	<brief_summary>Infants breast-fed HIV infect mother increase risk become infect HIV . Standard therapy prevention HIV infection infant include zidovudine ( ZDV ) prior onset labor , single dose nevirapine ( NVP ) woman labor , single dose NVP newborns give 72 hour birth . This study determine give low dose daily NVP breastfed infant HIV infect mother , addition standard therapy , effective standard therapy alone prevent HIV infection infant .</brief_summary>
	<brief_title>Daily Nevirapine Prevent Mother Infant Transmission HIV</brief_title>
	<detailed_description>This study evaluate safety effectiveness add daily infant NVP standard prevention measure decrease vertical transmission HIV . According current statistic study site , approximately 70 % pregnant HIV infect woman study begin antenatal ZDV prior initiation NVP labor . The remain 30 % HIV infect woman enrol trial previously undiagnosed . These woman diagnose HIV infection either time present delivery room stage 1 labor immediately postpartum present delivery late labor provide inform consent HIV screen prior delivery . All infant receive standard NVP 72 hour postpartum . Infants randomize receive either daily NVP daily multivitamin ( MVI ) daily MVI alone . Infants take NVP/MVI MVI alone Weeks 2 6 postpartum . The primary outcome measure infant HIV infection rate 6 month . Two additional relate cohort woman follow comparison : 1 ) equal number HIV uninfected woman child enrol comparison postpartum morbidity mortality ; 2 ) consent HIV infected woman child choose enroll clinical trial ineligible breastfeeding enrol ancillary cohort .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Nevirapine</mesh_term>
	<criteria>Inclusion Criteria Pregnant Postpartum Mothers HIV infect Planning breastfeed Able tolerate oral drug available 12 month postpartum followup Exclusion Criteria Significant physical emotional distress Infant serious life threaten disease severe fetal abnormality Obstetrical complication affect maternal health Prior antiretroviral drug ( except antenatal ZDV intrapartum ( NVP )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>Nevirapine</keyword>
	<keyword>Pregnancy</keyword>
	<keyword>Maternal Infant transmission</keyword>
	<keyword>Infant</keyword>
	<keyword>Breastfeeding</keyword>
	<keyword>HIV Seronegativity</keyword>
</DOC>